Seller record · Telehealth service
Emerge Weight Loss
Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published. The answers say every order undergoes quality and safety testing, with no report behind the claim. 1 more criterion also fails; see the table below.
At a glance
Emerge Weight LossTelehealth service
- Price
- Compounded tirzepatide from $224 per 4 weeks at the 2.5 mg starting dose; tablets from $149 a month
- Sells
- compounded tirzepatide injections, and 2 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A cash-pay telehealth weight loss program that prescribes compounded tirzepatide injections and dissolving tablets, with the medication, prescription, overnight shipping and care-team support in one price per four weeks. Care starts with an online intake reviewed by a medical team led by a board-certified family physician, and the company prints no postal address.
Operating entity Emerge Weight Loss, LLC
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Emerge Weight Loss' about page; Emerge Weight Loss' FAQ |
| S2 | Prescription gating | PASS | Emerge Weight Loss' pricing page; Emerge Weight Loss' weight loss program page |
| S3 | Pharmacy identification | PASS | Emerge Weight Loss' FAQ |
| S4 | Compounding disclosure | PASS | Emerge Weight Loss' FAQ; Emerge Weight Loss' terms |
| S5 | Analytical documentation | FAIL | Emerge Weight Loss' FAQ; Emerge Weight Loss' support page |
| S6 | Business address | FAIL | Emerge Weight Loss' support page; Emerge Weight Loss' terms; Emerge Weight Loss' privacy policy |
| S7 | Price disclosure | PASS | Emerge Weight Loss' pricing page; Emerge Weight Loss' tirzepatideodt page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded tirzepatide injections, compounded tirzepatide orally disintegrating tablets, NAD+ add-on.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.